Infant Formula with Palmitic Acid Triglycerides for Digestive Health

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current infant formulas do not adequately replicate the nutritional benefits of human breast milk, particularly in supporting gastrointestinal health, nutrient absorption, and immune system development, often leading to digestive issues and intolerance.

Innovation Solution

A nutritional formula comprising alpha-lactalbumin enriched whey protein, beta-casein enriched milk protein, lactoferrin, oleic acid-palmitic acid-oleic acid triglyceride, lutein, docosahexaenoic acid, arachidonic acid, and prebiotics, which mimics the composition of human breast milk to enhance digestion, absorption, and immune function.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional infant formula is used, then basic nutritional requirements are met, but gastrointestinal health and tolerance are compromised

Engineering Contradiction:

Improvegastrointestinal healthVSAvoiddigestive issues and intolerance

Core Design Contradiction:

ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent modifies the chemical composition parameters of the formula by incorporating specific ratios of hydrolyzed milk proteins (casein and whey), prebiotics, and probiotics to optimize gastrointestinal tolerance and health while maintaining nutritional adequacy

Inventive Principle:

Principle #35Parameter changes

Solution Approach 2:

The formula combines multiple functional components including hydrolyzed casein, hydrolyzed whey, prebiotics, and probiotics into a composite nutritional composition that synergistically supports gastrointestinal health and prevents intolerance

Inventive Principle:

Principle #40Composite materials

2Quantity of substance

If protein content is increased to support growth, then nutrient supply is improved, but risk of obesity increases

Engineering Contradiction:

Improvenutrient supplyVSAvoidobesity risk

Core Design Contradiction:

Quantity of substanceVSObject-affected harmful factors

Solution Approach 1:

The patent optimizes protein content parameters by using hydrolyzed proteins with controlled degrees of hydrolysis and specific casein-to-whey ratios, providing adequate amino acids for growth while preventing excessive protein intake that could lead to obesity

Inventive Principle:

Principle #35Parameter changes

3Object-affected harmful factors

If total protein content is reduced to prevent obesity, then obesity risk decreases, but immune protection and energy intake are compromised

Engineering Contradiction:

Improveobesity riskVSAvoidimmune protection

Core Design Contradiction:

Object-affected harmful factorsVSReliability

Solution Approach 1:

The formula incorporates specific functional proteins including lactoferrin and osteopontin that provide immune protection and energy intake support even at reduced total protein levels, maintaining health benefits while controlling obesity risk

Inventive Principle:

Principle #40Composite materials

Solution Approach 2:

The patent adjusts protein composition parameters by incorporating specific functional proteins with immunomodulatory and energy-regulating properties that maintain health benefits at lower total protein concentrations

Inventive Principle:

Principle #35Parameter changes

4Reliability

If docosahexaenoic acid is concentrated to improve retinal health, then vision development is enhanced, but oxidative degradation increases

Engineering Contradiction:

Improveretinal healthVSAvoidoxidative degradation

Core Design Contradiction:

ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent introduces lutein as an intermediary antioxidant substance that protects docosahexaenoic acid from oxidative degradation while allowing the DHA to remain concentrated for optimal retinal health benefits

Inventive Principle:

Principle #24Intermediary (Mediator)

Solution Approach 2:

The formula creates a protective chemical environment by incorporating antioxidants including lutein and vitamin E that prevent oxidative degradation of polyunsaturated fatty acids while maintaining their biological activity

Inventive Principle:

Principle #39Inert atmosphere (Inert environment)

Data Source

PatentUS20230141907A1Nutritional formula

Publication Date: 2023.05.11 BUILDING BLOCK NUTRITIONALS LLC

AI summary

The present disclosure provides a nutritional formula comprising alpha-lactalbumin enriched whey protein concentrate; beta-casein enriched milk protein; mildly hydrolyzed milk protein; osteopontin; lactoferrin; oleic acid-palmitic acid-oleic acid triglyceride, wherein palmitic acid is at the SN-2 position of the glycerol backbone of the triglyceride; lactose, wherein the lactose is reduced lactose; lutein; docosahexanoic acid; arachidonic acid; galactooligosaccharides; and polydextrose. The provided nutritional formulas may be useful in providing nutrition and/ or promoting postnatal development of a subject (e.g., promoting postnatal development of an infant’s gastrointestinal functions, nutrient absorption, immune system development, etc.). Also provided are powder forms, reconstituted formulas, kits, methods, and uses that include or involve a nutritional formula described herein.